EC
OVID icon

EcoR1 Capital’s Ovid Therapeutics OVID Stock Holding History

EcoR1 Capital’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,117,400
Closed -$18.7M – 63
2024
Q1 		$18.7M Hold
6,117,400
– – 0.47% 38
2023
Q4 		$19.7M Hold
6,117,400
– – 0.51% 31
2023
Q3 		$23.5M Hold
6,117,400
– – 0.8% 25
2023
Q2 		$20.1M Hold
6,117,400
– – 0.53% 28
2023
Q1 		$15.8M Hold
6,117,400
– – 0.51% 31
2022
Q4 		$11.4M Hold
6,117,400
– – 0.35% 35
2022
Q3 		$11.3M Hold
6,117,400
– – 0.33% 36
2022
Q2 		$13.2M Hold
6,117,400
– – 0.46% 36
2022
Q1 		$19.2M Buy
6,117,400
+35,200
+0.6% +$111K 0.6% 32
2021
Q4 		$19.5M Hold
6,082,200
– – 0.62% 27
2021
Q3 		$20.4M Hold
6,082,200
– – 0.72% 26
2021
Q2 		$23.8M Hold
6,082,200
– – 0.89% 26
2021
Q1 		$24.4M Buy
+6,082,200
New +$20.2M 1.09% 23

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return